CRIS Current Research Information System

BORSI, ENRICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.538
NA - Nord America 2.352
EU - Europa 1.832
AF - Africa 190
SA - Sud America 118
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.034
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.319
CN - Cina 703
SG - Singapore 683
VN - Vietnam 654
IT - Italia 530
GB - Regno Unito 326
DE - Germania 229
SE - Svezia 193
HK - Hong Kong 187
IN - India 127
NL - Olanda 110
KR - Corea 103
RU - Federazione Russa 96
BR - Brasile 89
FR - Francia 71
IE - Irlanda 68
CI - Costa d'Avorio 65
FI - Finlandia 40
TG - Togo 36
ZA - Sudafrica 35
SC - Seychelles 33
EE - Estonia 26
BG - Bulgaria 24
CH - Svizzera 24
AT - Austria 20
JP - Giappone 18
UA - Ucraina 18
CA - Canada 17
NG - Nigeria 17
IR - Iran 16
PL - Polonia 15
AR - Argentina 13
MX - Messico 13
BE - Belgio 11
ID - Indonesia 11
ES - Italia 10
JO - Giordania 8
BD - Bangladesh 6
CO - Colombia 5
EC - Ecuador 5
PH - Filippine 5
RO - Romania 5
CZ - Repubblica Ceca 3
LT - Lituania 3
TR - Turchia 3
UZ - Uzbekistan 3
AU - Australia 2
CY - Cipro 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
SV - El Salvador 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
NC - Nuova Caledonia 1
PA - Panama 1
PY - Paraguay 1
TW - Taiwan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.034
Salva come PNG Salva come JPEG
Città #
Singapore 453
Ashburn 318
Southend 284
Chandler 262
Hefei 216
Fairfield 204
Ho Chi Minh City 192
Hong Kong 187
Bologna 152
Hanoi 137
Ann Arbor 108
Seoul 103
Beijing 88
Wilmington 88
Dallas 85
Houston 83
Woodbridge 83
Seattle 78
Princeton 70
Cambridge 68
Dublin 68
Abidjan 65
Santa Clara 52
Boardman 50
Dong Ket 45
New York 43
Los Angeles 42
Milan 40
Lomé 36
Hyderabad 32
Munich 32
Nanjing 31
Helsinki 28
Westminster 28
Fabriano 27
Padova 26
Haiphong 25
Bremen 24
Sofia 24
Berlin 23
Bengaluru 21
Redondo Beach 20
Salsomaggiore Terme 20
Bern 19
Redmond 19
Tokyo 18
Jinan 17
Buffalo 16
Frankfurt am Main 16
Turin 15
Abeokuta 14
Amsterdam 14
Biên Hòa 14
Ha Long 14
Saint Petersburg 14
Vienna 14
Medford 13
Rome 13
Shenyang 13
Nanchang 12
Brussels 11
Falkenstein 11
Guangzhou 11
Hebei 11
Redwood City 11
São Paulo 11
Washington 11
Quận Bình Thạnh 10
Quận Một 10
Tianjin 10
Changsha 9
Falls Church 9
Lappeenranta 9
Mondolfo 9
Ninh Bình 9
Nuremberg 9
Toronto 9
Warsaw 9
Amman 8
Brooklyn 8
Florence 8
Shanghai 8
Thái Nguyên 8
Tongling 8
Wuhan 8
Yubileyny 8
Hangzhou 7
Jakarta 7
Norwalk 7
San Diego 7
Zhengzhou 7
Bắc Ninh 6
Casalecchio di Reno 6
Coimbatore 6
Da Nang 6
Jiaxing 6
Kuban 6
London 6
Naples 6
Quận Phú Nhuận 6
Totale 4.648
Salva come PNG Salva come JPEG
Nome #
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma 663
BoBafit: A copy number clustering tool designed to refit and recalibrate the baseline region of tumors’ profiles 234
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment 230
The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD) 199
Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells 193
Treatment optimization for Multiple Myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in an in vitro and ex-vivo model 175
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients 173
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens 171
Inter-Cell Networking Profiling Enables Comprehensive Characterization of Immune-Mediated Activity of Anti-CD38 Therapy through Ex-Vivo Analysis of Multiple Myeloma Patients 169
Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma. 168
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis 168
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases 159
Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor 153
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients 152
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia 152
Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma 152
High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53 150
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma 150
Cap dependent translation contributes to resistance of myeloma cells to bortezomib 148
Genomic characterization of the putative myeloma stem cells clone reveals alterations possibly correlated with the origin of disease. 148
HIF 1 Alpha: A Suitable Target for Multiple Myeloma 148
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment 146
HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA 137
Analysis of mismatch repair gene mutations in Turkish HNPCC patients 134
Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5 133
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma 131
High CNA level and over-expression of genes involved in response mechanisms to genotoxic stress characterize newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted TP53 129
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis 128
Relative role ofAPCandMUTYHmutations in the pathogenesis of familial adenomatous polyposis 127
SIRT regulates the molecular interaction between c-MYC and HIF-1 alpha in multiple myeloma 124
OAB-006: A novel algorithm to identify, characterize and define the prognostic impact of complex catastrophic events in Multiple Myeloma 122
Impact Of p53 Impaired Function On Outcomes Of Multiple Myeloma Patients Carrying Deleted TP53 and/Or Amplified MDM4 120
Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma 118
VarianThinker: a classification method to confidently approach the mutation heterogeneity in Multiple Myeloma 117
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features 115
A Methodologically Updated De-Novo Extraction of Copy Number Signatures in Multiple Myeloma: Clinical Significance and Putative Aetiologies 110
Rare, but complex chromosomal rearrangements, defined "Chromoanagenesis”, caused by single-step or stepwise catastrophic genomic events, significantly impact on Multiple Myeloma patients 110
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets 108
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients 108
Italian cancer figures, report 2012: Cancer in children and adolescents. 98
null 98
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients 97
Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma 96
AIRTUM numbers: 200,000 young Italians live with cancer 92
[Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients]. 88
[Italian cancer figures, report 2011: Survival of cancer patients in Italy]. 85
Loss of nuclear beta catenin, following chibby enforced expression, activates endoplasmic reticulum stress in cells expressing the BCR-ABL1 fusion gene of chronic myeloid leukemia 72
OAB-057: Temporal-weight estimation of the copy number alterations of of 1384 Multiple Myeloma patients defines an ancestrality index impacting patients survival 60
Abstract 2700: Negative selective pressure exerted by maintenance therapy promotes the extinction of sub-clones carrying high-risk lesions in multiple myeloma 50
IMPLEMENTATION OF NEXT GENERATION SEQUENCING AS BEST TOOL FOR ROUTINE EVALUATION OF MINIMAL RESIDUAL DISEASE IN THE DAILY PRACTICE OF MULTIPLE MYELOMA PATIENTS 42
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma 29
Totale 7.179
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.949
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021273 0 0 0 0 0 16 6 20 60 13 11 147
2021/2022742 32 36 41 48 65 41 20 41 42 103 121 152
2022/20231.009 80 133 43 153 79 83 30 47 144 57 81 79
2023/2024450 32 44 46 37 30 86 26 84 12 13 24 16
2024/20251.293 81 130 105 111 119 56 98 49 34 131 122 257
2025/20262.257 346 854 291 291 349 126 0 0 0 0 0 0
Totale 7.179